Astrana Health, Inc. (NASDAQ:ASTH) Receives $41.33 Consensus Target Price from Analysts

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have earned a consensus recommendation of “Moderate Buy” from the eleven analysts that are presently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, one has issued a hold recommendation and eight have given a buy recommendation to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $41.3333.

A number of brokerages have recently commented on ASTH. Needham & Company LLC initiated coverage on Astrana Health in a report on Friday, December 12th. They issued a “buy” rating and a $28.00 price target on the stock. TD Cowen cut their target price on Astrana Health from $40.00 to $35.00 and set a “buy” rating on the stock in a research note on Monday, November 10th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Astrana Health in a research report on Monday, December 29th. Barclays decreased their price target on shares of Astrana Health from $36.00 to $26.00 and set an “equal weight” rating for the company in a research note on Monday, November 24th. Finally, Jefferies Financial Group reiterated a “buy” rating on shares of Astrana Health in a report on Tuesday, November 25th.

Astrana Health Trading Up 0.1%

NASDAQ:ASTH opened at $28.22 on Tuesday. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.40 and a quick ratio of 1.40. The business’s 50-day simple moving average is $24.49 and its 200-day simple moving average is $26.75. Astrana Health has a fifty-two week low of $20.12 and a fifty-two week high of $39.97. The stock has a market capitalization of $1.59 billion, a PE ratio of 148.53, a price-to-earnings-growth ratio of 0.70 and a beta of 0.87.

Astrana Health (NASDAQ:ASTH) last announced its earnings results on Wednesday, January 10th. The company reported $0.50 EPS for the quarter. The firm had revenue of $317.00 million for the quarter. Astrana Health had a net margin of 0.33% and a return on equity of 1.26%. Sell-side analysts expect that Astrana Health will post 1.15 earnings per share for the current fiscal year.

Institutional Trading of Astrana Health

A number of hedge funds and other institutional investors have recently modified their holdings of ASTH. Ameriprise Financial Inc. boosted its position in Astrana Health by 231.0% during the third quarter. Ameriprise Financial Inc. now owns 442,314 shares of the company’s stock valued at $12,540,000 after purchasing an additional 308,665 shares during the last quarter. 325 Capital LLC boosted its holdings in shares of Astrana Health by 34.6% in the 3rd quarter. 325 Capital LLC now owns 1,193,953 shares of the company’s stock valued at $33,849,000 after buying an additional 307,037 shares during the last quarter. Pacer Advisors Inc. bought a new position in shares of Astrana Health in the third quarter valued at $5,157,000. Jacobs Levy Equity Management Inc. grew its stake in shares of Astrana Health by 211.6% in the first quarter. Jacobs Levy Equity Management Inc. now owns 237,926 shares of the company’s stock valued at $7,378,000 after buying an additional 161,580 shares in the last quarter. Finally, Insight Wealth Strategies LLC acquired a new position in Astrana Health during the fourth quarter worth $3,514,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.